ORGO: Organogenesis Holdings Inc. Class A Common Stock Company Profile & Statistics

About

Organogenesis is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.

Info & Links

CEO

Gary S. Gillheeney, Sr.

Headquarters

85 Dan Road
Canton, MA 02021, UNITED STATES

Auditor

RSM US LLP

Share holders

585

Employees

869

Organogenesis Holdings Inc. Class A Common Stock Statistics

Valuation Measures

Market Capitalization²

395.78M

Enterprise Value

286.85M

Enterprise Value/EBITDA(ttm)

219.98

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.93

Price to Book(mrq)

1.61

Price to Cash(ytd)

15.72

Profitability

Gross Margin(ttm)

75.61%

Operating Margin(ttm)

-1.62%

Profit Margin(ttm)

-5.66%

Return on Equity(ttm)

-2.69%

Return on Invested Capital(ttm)

-6.44%

Return on Assets(ttm)

-1.63%

Income Statement

Revenue(ttm)

458.76M

Revenue Per Share(ttm)

3.62

Gross Profit(ttm)

347.99M

EBITDA(ttm)³

1.30M

Net Income Available to Common(ttm)

-20.43M

Diluted EPS(ttm)

-0.06

Share Statistics

Beta (5Y Monthly)

1.77

52-Week Change

23.05%

S&P 500 52-Week Change

9.20%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

126.85M

Dividend Yield

0.00%

Float⁴

79.33M

% Held by Insiders

36.90%

% Held by Institutions

49.57%

Balance Sheet

Total Cash(mrq)

110.53M

Total Cash Per Share(mrq)

0.87

Total Debt(mrq)

1.60M

Total Debt/Equity(mrq)

0.66%

Current Ratio(mrq)

4.12%

Quick Ratio(mrq)

2.74%

Book Value Per Share(mrq)

1.91

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.16

Free Cash Flow(ytd)

-23.56M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ORGO

Organogenesis Holdings Inc. Class A Common Stock

Organogenesis Holdings Inc. Class A Common Stock Profile